Western blot analysis showed that SUMO1 modification levels were lower in ccRCC tumors derived from SENP1 overexpressing cells relative to control cells (Supplementary Fig. 2A), thus confirming SENP1 was active in the tumors. The gene discussed is SENP1; the disease is nonpapillary renal cell carcinoma.